Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors

Clinical Journal of Gastroenterology · Published 2026-07-07 · DOI 10.1007/s12328-026-02388-z

Authors (10)

Sho Tazuma, Takeshi Sudo, Kenta Baba, Takashi Onoe, Tatsuaki Sumiyoshi, Kazuya Kuraoka, Kenichiro Uemura, Shinya Takahashi, Hirotaka Tashiro, Yosuke Shimizu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tazuma, S., Sudo, T., Baba, K., et al. (2026). Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02388-z

Related articles